The Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) — which includes Canada, the European Union, Norway, and the United States — is launching its fourth implementation phase since 2009 to continue combating antimicrobial resistance (AMR). The 2021-2026 draft work plan includes new collaboration areas such as sewage-based surveillance, modeling transmission of AMR pathogens, and diagnostic stewardship.
The organization also announced that the United Kingdom has joined the group.
In the next implementation period, TATFAR will continue to collaborate and share best practices that strengthen domestic and global efforts across four key areas:
· Appropriate antimicrobial use in human and veterinary medicine
· Surveillance and prevention of AMR
· Strategies to improve financial incentives, access, research, and development of antimicrobial drugs, diagnostics, and alternatives
· Cross-cutting actions to improve awareness about AMR and appropriate use of antibiotics, and to disseminate information from TATFAR
The draft workplan will be formally adopted later in 2021. The Centers for Disease Control and Prevention (CDC) participates in TATFAR as a U.S. member agency and as the task force secretariat.
